Organization Overview
Alternative names
10-valent Pneumococcal Conjugate Vaccine (Pneumosil) (1 trial)
albendazole (Albenza) (5 trials)
amodiaquine (camoquin) (2 trials)
emtricitabine (emtriva) (4 trials)
ethambutol (myambutol) (1 trial)
gentamicin (garamycin) (1 trial)
human papillomavirus 9-valent vaccine, recombinant (Gardasil 9) (1 trial)
human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil) (1 trial)
isoniazid (nydrazid) (2 trials)
ivermectin (stromectol) (3 trials)
miltefosine (impavido) (3 trials)
moxifloxacin (avelox) (2 trials)
pancrelipase (creon) (1 trial)
paromomycin (humatin) (1 trial)
polio, inactivated poliovirus vaccine (Salk Vaccine) (1 trial)
abhayrab rabies vaccine (1 trial)
acellular pertussis vaccine (including diptheria and tetanus toxoids) (Tripedia) (2 trials)
amphotericin b (fungizone) (1 trial)
ceftriaxone (rocephin) (1 trial)
fluconazole (diflucan) (1 trial)
flucytosine (ancobon) (1 trial)
haemophilus influenzae type b conjugate vaccine (HibTITER) (1 trial)
hepatitis b vaccine (recombinant) (Recombivax) (1 trial)
Anemia (Phase 3)
Child Nutrition Disorders (Phase 3)
Coinfection (Phase 4)
Communicable Diseases (Phase 4)
Diarrhea (Phase 4)
Dysentery, Bacillary (Phase 2)
Gonorrhea (Phase 4)
Helminthiasis (Phase 4)
HIV Infections (Phase 2)
Infections (Phase 4)
Influenza, Human (Phase 3)
Leishmaniasis (Phase 3)
Leishmaniasis, Visceral (Phase 3)
Malaria (Phase 4)
Malaria, Falciparum (Phase 4)
Malnutrition (Phase 4)
Nematode Infections (Phase 4)
Nutrition Disorders (Phase 3)
Opportunistic Infections (Phase 4)
Papillomavirus Infections (Phase 3)
Parasitemia (Phase 2)
Pneumonia (Phase 4)
Pneumonia, Pneumococcal (Phase 2)
Scabies (Phase 2)
Severe Acute Malnutrition (Phase 3)
Sexually Transmitted Diseases (Phase 4)
Syphilis (Phase 4)
Tinea Capitis (Phase 3)
Tuberculosis (Phase 3)
Tuberculosis, Pulmonary (Phase 3)